CG Oncology, Inc. Common stock
CGON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45 | $15 | $41 | $257 |
| Short-Term Investments | $635 | $646 | $647 | $485 |
| Receivables | $1 | $1 | $0 | $1 |
| Inventory | $2 | $0 | $0 | $0 |
| Other Curr. Assets | $14 | $11 | $12 | $11 |
| Total Curr. Assets | $696 | $673 | $701 | $754 |
| Property Plant & Equip (Net) | $20 | $1 | $1 | $0 |
| Goodwill | $13 | $0 | $0 | $0 |
| Intangibles | $2 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $27 | $26 | $0 |
| Total NC Assets | $34 | $28 | $27 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $730 | $701 | $728 | $755 |
| Liabilities | – | – | – | – |
| Payables | $9 | $7 | $7 | $7 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $20 | $23 | $16 | $15 |
| Total Curr. Liab. | $31 | $30 | $23 | $21 |
| LT Debt | $6 | $1 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $0 | $0 | $0 |
| Total NC Liab. | $12 | $1 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $1 | $1 | $0 |
| Total Liabilities | $42 | $31 | $23 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$338 | -$294 | -$252 | -$218 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $1,025 | $964 | $957 | $951 |
| Total Equity | $688 | $670 | $705 | $733 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $730 | $701 | $728 | $755 |
| Net Debt | -$38 | -$14 | -$40 | -$257 |